Phase II study of non-myeloablative allogeneic bone marrow transplantation for B-cell lymphoma with post-transplantation rituximab and donor selection based first on non-HLA factors

Outcomes of non-myeloablative (NMA), HLA-haploidentical (haplo) related-donor allogeneic blood or marrow transplantation (allo BMT) with high-dose posttransplantation cyclophosphamide (PTCy) appear to be similar to those using HLA-matched donors. Thus, it may be possible to prioritize donor factors...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Kanakry, Jennifer A., Gocke, Christopher D., Bolaños-Meade, Javier, Gladstone, Douglas E., Swinnen, Lode J., Blackford, Amanda L., Fuchs, Ephraim J., Ann Huff, Carol, Borrello, Ivan, Matsui, William H., Brodsky, Robert A., Rosner, Gary L., Shanbhag, Satish, Luznik, Leo, Jones, Richard J., Ambinder, Richard F., Kasamon, Yvette L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639455/
https://ncbi.nlm.nih.gov/pubmed/26183076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.07.012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados